Coriobacteriia  Can Affect The Developing of Hepatocellular Carcinoma Through The Pyrimidine, Caffeine, Urea Cycle and Glutamate Metabolic Pathways

Author:

Dai Jingyi1,Li Qiujing1,Chen Jie1,Dong Zhijian1,Ma Zhongxu1,Luo Yu1,Liu Guiming1

Affiliation:

1. The Third People's Hospital of Kunming

Abstract

Abstract

Background Most patients with hepatocellular carcinoma (HCC) lose the chance of survival due to lack of timely diagnosis and effective treatment. The specific gut microbiota (GM) spectrum may become the target of early diagnosis and treatment of HCC. However, the metabolic mechanisms that affect the occurrence of liver cancer are still unclear. Methods In this study, we called the dataset of HCC, and 1,091 serum metabolites 309 metabolite ratios as well as 211 GM taxa through GWAS instrumental variables for Mendelian randomization causal association analysis and metabolome intermediary effects exploration. Through functional enrichment of intermediate metabolites, the effects of metabolic pathways involved in GM on HCC were analyzed. Inverse variance weighting (IVW) was the main model for establishing causal associations. Additionally horizontal pleiotropy test, linkage disequilibrium test and sensitivity analysis were employed to test the explanatory power of instrumental variables (SNPs). Results Our study found Coriobacteriia class, Coriobacteriales order, Coriobacteriaceae family, and 4 specific genera were strongly related to HCC (P < 0.05). Meanwhile, through two samples-MR Analysis , 49 metabolites levels/ratios were shown to be closely related to the development of HCC. A total of 10 related metabolic intermediary factors have been selected, and 4 metabolic pathways of Pyrimidine (P = 0.0031), Caffeine(P = 0.0072), Urea Cycle (P = 0.0105) and Glutamate (P = 0.0298) were significantly enriched in this GM related HCC process. Conclusion Coriobacteriia class and its lower taxa were associated with the risk factors of developing HCC through the regulation of Pyrimidine, Caffeine, Urea Cycle and Glutamate metabolic pathways. These biomarkers may become targets for HCC early diagnosis and immunotherapy.

Publisher

Springer Science and Business Media LLC

Reference51 articles.

1. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang JD;Nat Rev Gastroenterol Hepatol,2019

2. Global, regional and national burden of primary liver cancer by subtype;Rumgay H;Eur J Cancer,2022

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

4. Reply: A multi-society delphi consensus statement on new fatty liver disease nomenclature;Lazarus JV;Hepatology,2023

5. Biomarkers in hepatocellular carcinoma: an overview;Juarez-Hernandez E;Expert Rev Gastroenterol Hepatol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3